EcoR1 Capital’s Kindred Biosciences, Inc. KIN Stock Holding History

EcoR1 Capital’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-248,680	Closed	-$2.15M	–	45
2018 Q1	$2.15M	Sell	248,680 -296,200	-54%	-$2.6M	0.22%	30
2017 Q4	$5.15M	Hold	544,880	–	–	0.58%	24
2017 Q3	$4.28M	Hold	544,880	–	–	0.57%	27
2017 Q2	$4.69M	Hold	544,880	–	–	0.83%	20
2017 Q1	$3.84M	Sell	544,880 -26,246	-5%	-$164K	0.97%	17
2016 Q4	$2.43M	Sell	571,126 -861,639	-60%	-$4.17M	0.77%	19
2016 Q3	$7.15M	Hold	1,432,765	–	–	2.19%	17
2016 Q2	$5.07M	Hold	1,432,765	–	–	2%	18
2016 Q1	$4.94M	Hold	1,432,765	–	–	1.73%	22
2015 Q4	$4.87M	Buy	1,432,765 +109,334	+8%	+$507K	1.53%	18
2015 Q3	$6.88M	Buy	1,323,431 +29,000	+2%	+$179K	3.13%	12
2015 Q2	$8.83M	Hold	1,294,431	–	–	2.94%	10
2015 Q1	$9.24M	Hold	1,294,431	–	–	3.08%	13
2014 Q4	$9.64M	Buy	+1,294,431	New	+$11M	4.88%	9

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

PVAM

Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return

EcoR1 Capital's KIN Position: Q2 2018 in Review

EcoR1 Capital sold out of Kindred Biosciences, Inc. (KIN) in Q2 2018, closing a stake of 248,680 shares — an estimated $2.15M sold.

EcoR1 Capital first reported a position in KIN in Q4 2014 and held it in 14 quarters. The position peaked at $9.64M in Q4 2014. 73 funds tracked by Wall St. Rank hold KIN as of Q2 2018.

EcoR1 Capital reported no remaining Kindred Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
EcoR1 Capital sold 248,680 Kindred Biosciences, Inc. shares in Q2 2018, an estimated $2.15M.
EcoR1 Capital first reported a position in Kindred Biosciences, Inc. in Q4 2014 and held it in 14 quarters.
EcoR1 Capital's Kindred Biosciences, Inc. position peaked at $9.64M in Q4 2014.
73 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2018.

Based on EcoR1 Capital's 13F filing for Q2 2018, filed 14 Aug 2018.